1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Everest Medicines

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Type

Investment Company

Location

Shanghai China

Alternative Asset Classes

PE

Firm Ownership

-

Investment Team Staff

Total Staff

-
Everest Medicines operates as an incubator of C-Bridge Capital, aiming to in-license, develop and commercialize pharmaceutical products in China. The firm also plans to introduce healthcare drugs from US to China.
Asset Class No. of Funds Currently Managed Funds Raised in Last 10 Years Est. Dry Powder Strategies
Private Equity - Early Stage: Seed, Early Stage: Start-up
Real Estate - -
Private Debt - -
Infrastructure - -
Natural Resources - -
Asset Class No. of Funds Currently Managed AuM Date of AuM Strategies
Hedge Funds 0 -

Want to see more?

Request a demo for full access to this profile.

7 Known Decision Makers

Contact Name Position Location Email Telephone Asset Class
Chief Business Officer Shanghai, China PE VC
Chief Executive Officer Shanghai, China PE VC
Director, Alliance Management & Business Development Jiaxing City, China PE VC
Executive Director, Business Development & Alliance Management Shanghai, China PE
President & Chief Financial Officer Executive Director, President and Chief Financial Officer Shanghai, China PE

Showing 5 of 7 known decision makers at Everest Medicines

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.